Stereotaxis Stock Price and Value Analysis

Should you buy Stereotaxis stock? (Other OTC:STXS). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company is not making money.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the STXS Numbers

STXS Price
(Stereotaxis stock price per share)
[?] PE Ratio versus Sector 14% higher than other Healthcare stocks
[?] PE Ratio versus Industry 3% lower than other Medical Instruments & Supplies stocks
[?] Cash Yield -1.70%
[?] Free Cash Flow Jitter 64%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,632,426 shares shorted. With 57,156,818 shares available for purchase and an average trading volume over the past 10 trading days of 178,250, it would take at least 9.158 days for all of the short holders to cover their shorts.

Is Stereotaxis Stock on Sale?

Based on our analysis, we believe that you should not buy Stereotaxis right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy STXS Stock?

Does Stereotaxis have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.